Cibenzoline induced Brugada ECG pattern | Zendy

Andrea Sarkozy | Zendy; Axel Caenepeel | Zendy; P. Geelen | Zendy; P PEYTCHEV | Zendy; M DEZUTTER | Zendy; Pedro Brugada | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cibenzoline induced Brugada ECG pattern

Author(s) -

Andrea Sarkozy,

Axel Caenepeel,

P. Geelen,

P PEYTCHEV,

M DEZUTTER,

Pedro Brugada

Publication year - 2005

Publication title -

ep europace

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1016/j.eupc.2005.06.013

Subject(s) - medicine , ajmaline , brugada syndrome , cardiology , right bundle branch block , bundle branch block , palpitations , sodium channel blocker , st segment , electrocardiography , flecainide , discontinuation , st elevation , anesthesia , atrial fibrillation , sodium channel , myocardial infarction , chemistry , organic chemistry , sodium

We report a case of a 61-year-old female patient who presented with palpitations. The baseline electrocardiogram showed incomplete right bundle branch block with saddle back pattern of the ST segment in one precordial lead, but without any significant ST elevation. She was treated with oral cibenzoline. The subsequent ECG showed a coved Brugada ECG (type I) pattern, which resolved following the discontinuation of cibenzoline. An ajmaline test reproduced the coved type Brugada ECG pattern. Our case is the first report of oral cibenzoline therapy unmasking the diagnostic coved Brugada ECG pattern in a patient with a baseline normal ECG. Cibenzoline, a class I sodium channel blocker antiarrhythmic drug, should probably be avoided in the treatment of patients with Brugada syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research